Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
25.87
+0.05 (0.19%)
At close: Jan 23, 2026, 4:00 PM EST
25.75
-0.12 (-0.46%)
After-hours: Jan 23, 2026, 6:53 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Biotechnology
14.02M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
14.02M